Compagnie Lombard Odier SCmA’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-44,500
Closed -$724K 461
2024
Q1
$724K Sell
44,500
-5,000
-10% -$78.2K 0.01% 172
2023
Q4
$738K Hold
49,500
0.01% 191
2023
Q3
$556K Hold
49,500
0.01% 181
2023
Q2
$498K Buy
+49,500
New +$459K 0.01% 176

Other funds holding ELAN

Compagnie Lombard Odier SCmA's ELAN Position: Q2 2024 in Review

Compagnie Lombard Odier SCmA sold out of Elanco Animal Health (ELAN) in Q2 2024, closing a stake of 44,500 shares — an estimated $724K sold.

Compagnie Lombard Odier SCmA first reported a position in ELAN in Q2 2023 and held it in 4 quarters. The position peaked at $738K in Q4 2023. 402 funds tracked by Wall St. Rank hold ELAN as of Q2 2024.

  • Compagnie Lombard Odier SCmA reported no remaining Elanco Animal Health position as of Q2 2024 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 44,500 Elanco Animal Health shares in Q2 2024, an estimated $724K.
  • Compagnie Lombard Odier SCmA first reported a position in Elanco Animal Health in Q2 2023 and held it in 4 quarters.
  • Compagnie Lombard Odier SCmA's Elanco Animal Health position peaked at $738K in Q4 2023.
  • 402 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2024.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2024, filed 18 Jul 2024.